Citation Impact

Citing Papers

Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions
2007 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Risk-Benefit Profile of Warfarin Versus Aspirin in Patients With Heart Failure and Sinus Rhythm
2012
Guidelines for the Primary Prevention of Stroke A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
2011
No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based study
2000
Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study
2008 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
A critical review of the diagnosis and management of Barrett’s esophagus: the AGA Chicago Workshop1 1Members of the workshop composed a group of international experts in BE from gastroenterology, surgery, pathology, molecular biology, outcomes, and epidemiology. Conference chairman: Prateek Sharma; conference moderator: Kenneth McQuaid; group leaders: John Dent, M. Brian Fennerty, Richard Sampliner, Stuart Spechler; participants: Alan Cameron, Douglas Corley, Gary Falk, John Goldblum, John Hunter, Janusz Jankowski, Lars Lundell, Brian Reid, Nicholas Shaheen, Amnon Sonnenberg, Kenneth Wang, and Wilfred Weinstein.
2004
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
2010 Standout
White blood cell count, coronary heart disease, and death: The NHANES I Epidemiologic Follow-up Study
1993
Interventions for enhancing medication adherence
2005
Drug Addiction
2003
Rats on the grog: Novel pharmacotherapies for alcohol craving
2004
Cellular pathophysiology of ischemic acute kidney injury
2011 Standout
Pharmacological Prevention of Thromboembolism in Patients with Left Ventricular Dysfunction
2006
Emerging oral therapies for multiple sclerosis
2007
Warfarin versus Aspirin for Prevention of Stroke in Heart Failure: A Meta-analysis of Randomized Controlled Clinical Trials
2012
The Recurrence of Acute Alcohol-Associated Pancreatitis Can Be Reduced: A Randomized Controlled Trial
2008
The Primary and Secondary Prevention of Coronary Artery Disease
2008
Leukocytes as a coronary risk factor in a dyslipidemic male population
1992
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
C-reactive protein: a critical update
2003 Standout
Esophageal Cancer
2003 Standout
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
2005 Standout
What Makes Clinical Research Ethical?
2000 Standout
Chinese Guidelines for the Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack 2010
2012
Guidelines for the Primary Prevention of Stroke
2010
Update on recent clinical trials in congestive heart failure
2000
Acute Pancreatitis
2016 Standout
Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris
2001
Antithrombotic Therapy for VTE Disease
2012 Standout
Warfarin Versus Aspirin in Patients With Reduced Cardiac Ejection Fraction (WARCEF): Rationale, Objectives, and Design
2006
Association of Fibrinogen, C-reactive Protein, Albumin, or Leukocyte Count With Coronary Heart Disease
1998 Standout
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease
2000
Oesophageal carcinoma
2013 Standout
C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease
2004 Standout
Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma
1999 Standout
Elevated C-Reactive Protein Levels in Overweight and Obese Adults
1999 Standout
Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: A randomized prospective trial assessing efficacy and cost-effectiveness
2005
Reporting of Adherence to Medication in Recent Randomized Controlled Trials of 6 Chronic Diseases: A Systematic Literature Review
2007
The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus
2006 Standout
Barrett's oesophagus
2009
Primary and Secondary Prevention of Cardiovascular Disease
2012
Variable pathologic interpretation of columnar lined esophagus by general pathologists in community practice
1999
Association of peripheral neutrophilia with adverse angiographic outcomes in ST-elevation myocardial infarction
2004
Imaginary Relish and Exquisite Torture: The Elaborated Intrusion Theory of Desire.
2005 Standout
Education by a Nurse Increases Response of Patients With Chronic Hepatitis C to Therapy With Peginterferon-α2a and Ribavirin
2011
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Asthmatics With Gastroesophageal Reflux: Long Term Results of A Randomized Trial of Medical and Surgical Antireflux Therapies
2003
Electronic monitoring and counseling to improve medication adherence
2003
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Threats to Applicability of Randomised Trials: Exclusions and Selective Participation
1999
The Status of Naltrexone in the Treatment of Alcohol Dependence
2006
Usefulness of narrow-band imaging endoscopy for diagnosis of Barrett?s esophagus
2004
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Adherence to Medication
2005 Standout
Clinical trials update and cumulative meta‐analyses from the American College of Cardiology: WATCH, SCD‐HeFT, DINAMIT, CASINO, INSPIRE, STRATUS‐US, RIO‐Lipids and cardiac resynchronisation therapy in heart failure
2004
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Markers of Inflammation and Cardiovascular Disease
2003 Standout
Leukocyte Count as an Independent Predictor of Recurrent Ischemic Events
2004
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
2009 Standout
Interventions for enhancing medication adherence
2008 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
Leukocytes and the Risk of Ischemic Diseases
1987
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
Secondary prevention by enhancing adherence in diabetic patients.
2010
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006
A circadian gene expression atlas in mammals: Implications for biology and medicine
2014 Standout
Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease
2018
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Monitoring clinical research: an obligation unfulfilled.
1995
Interventions for enhancing medication adherence
2014 Standout
Association Between White Blood Cell Count, Epicardial Blood Flow, Myocardial Perfusion, and Clinical Outcomes in the Setting of Acute Myocardial Infarction
2000
Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure
2001 StandoutNobel
A Heck–Matsuda Process for the Synthesis of β‐Arylethenesulfonyl Fluorides: Selectively Addressable Bis‐electrophiles for SuFEx Click Chemistry
2016 StandoutNobel
Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men
2000 Standout
Development and validation of a predictive model for chemotherapy-associated thrombosis
2008 Standout
Development of a Point of Care Lateral Flow Device for Measuring Human Plasma Fibrinogen
2010 StandoutNobel
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
Medication Adherence
2009 Standout
High-Dose Atorvastatin after Stroke or Transient Ischemic Attack
2006 Standout
Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients
2009
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged Men
1999 Standout
Effect of Segment Length on Risk for Neoplastic Progression in Patients with Barrett Esophagus
2000

Works of W Król being referenced

Naltrexone in the Treatment of Alcohol Dependence
2001
Development for and results of the use of a gastroesophageal reflux disease activity index as an outcome variable in a clinical trial
1994
The Warfarin and Antiplatelet Therapy in Heart Failure Trial (WATCH): rationale, design, and baseline patient characteristics
2004
Medication Compliance Feedback and Monitoring in a Clinical Trial: Predictors and Outcomes
2003
Comparison of eligible randomized patients with two groups of ineligible patients: Can the results of the VA total parenteral nutrition clinical trial be generalized?
1993
Warfarin and antiplatelet therapy study in chronic heart failure (WATCH): Trial design
1999
External quality control programs
1983
Diagnostic inconsistencies in Barrett's esophagus
1994
The effects of antireflux therapy on pulmonary function in patients with severe gastroesophageal reflux disease. Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group.
1995
Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure
2009
White Blood Cell Count and Haematocrit as Predictors of Coronary Recurrence after Myocardial Infarction
1985
Rankless by CCL
2026